Our trial of ondansetron as a treatment for hallucinations in Parkinson's is restarting Date 22 November 2024
Poems for World Parkinson's Day 2022 Date 26 April 2022 The Parkinson's community came together to share their Parkinson's story through poetry.
Alex Echo and Hydrow partner up for Parkinson's Date 24 April 2022 A new partnership between Alex Echo, Hydrow and Parkinson’s UK will raise awareness of Parkinson’s and the benefits of physical activity.
New smartwatch has potential to enhance personalised Parkinson’s care Date 19 April 2022 As a new clinical trial begins, we explore the potential and next steps for a Parkinson’s watch that monitors symptoms.
James Jopling joins Parkinson’s UK as Scotland Director Date 14 April 2022 James, who was most recently with the British Heart Foundation, replaces Annie Macleod who retired at the end of last year.
Mr Motivator partners with Parkinson’s UK for World Parkinson’s Day Date 6 April 2022 To celebrate World Parkinson’s Day, the legendary fitness instructor is using his free Wednesday Fizzical online class as a platform to get people talking about Parkinson’s.
Caption Husband and wife look out the window Pioneering clinical trial opens new sites Date 6 April 2022 The TOP HAT clinical trial for visual hallucinations in Parkinson's and Lewy body dementia has recently opened 4 new trial sites.
Everyone Active offers free membership for people with Parkinson’s and their carers Date 5 April 2022 Physical activity is good for you. It’s especially good for you if you have Parkinson’s. That’s why we’ve partnered with Everyone Active to offer free membership to its leisure centres for people with Parkinson’s and their carers.
Investigating an app to improve non-motor symptom management Date 21 March 2022 An app for people with Parkinson’s to remotely monitor and manage their non-motor symptoms is now entering the testing phase.
Research reveals impact of the pandemic on the Parkinson's community Date 21 March 2022 New research from Lancaster University reveals the imapct of the pandemic on people with Parkinson's, carers and their families
Nanobodies that target LRRK2 could have potential for Parkinson's Date 7 March 2022 Treatments targeting a protein called LRRK2 are currently being tested in clinical trials for Parkinson's. Researchers hope they may have the ability to slow the progression of the condition which is something no current treatment can do.
